Table 4 Blood routine results of patients with COVID-19 at hospital admission in overall population and by disease severitya
| Â | Â | Patients | Mild | Moderate | Severe | P |
|---|---|---|---|---|---|---|
Subjects, n |  | 41 | 5 | 28 | 8 | – |
WBC (3.5–9.5 × 109/L) | Normal | 36 (87.8) | 5 (100) | 26 (92.9) | 5 (62.5) | 0.046 |
| Â | Low | 5 (12.2) | 0 | 2 (7.1) | 3 (37.5) | Â |
Lymphocyte percentage (20–40%) | Normal | 26 (63.4) | 3 (60) | 18 (64.3) | 5 (62.5) | 0.398 |
| Â | Low | 15 (36.6) | 2 (40) | 10 (35.7) | 3 (37.5) | Â |
Lymphocyte count (1.1–3.2 × 109/L) | Normal | 23 (56.1) | 5 (100) | 17 (60.7) | 1 (12.5) | 0.006 |
| Â | Low | 18 (43.9) | 0 | 11 (39.3) | 7 (87.5) | Â |
CRP (0–6 mg/L) | Normal | 19 (46.3) | 5 (100) | 14 (50) | 0 | 0.002 |
| Â | Elevated | 22 (53.7) | 0 | 14 (0) | 8 (100) | Â |
LDH (109–24 U/L) | Normal | 32 (78) | 5 (100) | 24 (87.5) | 3 (62.5) | 0.007 |
| Â | Elevated | 9 (22) | 0 | 4 (14.3) | 5 (62.5) | Â |
CK (26–174 U/L) | Normal | 35 (85.4) | 5 (100) | 25 (89.3) | 5 (62.5) | 0.103 |
| Â | Elevated | 6 (14.6) | 0 | 3 (10.7) | 3 (37.5) | Â |
CK-MB (0–24 U/L) | Normal | 33 (80.5) | 4 (80) | 23 (82.1) | 6 (75) | 0.903 |
| Â | Elevated | 8 (19.5) | 1 (20) | 5 (17.9) | 2 (25) | Â |
CTnI (0–0.5 ng/mL) | Normal | 0 | 0 | 0 | 0 | 0.621 |
| Â | Elevated | 41 (100) | 5 (100) | 28 (100) | 8 (100) | Â |
Myoglobin (0–85 mg/mL) | Normal | 30 (73.2) | 5 (100) | 23 (82.1) | 2 (25) | 0.002 |
| Â | Elevated | 11 (26.8) | 0 | 5 (17.9) | 6 (75) | Â |
AST (8–40 U/L) | Normal | 35 (85.4) | 5 (100) | 23 (82.1) | 7 (87.5) | 0.571 |
| Â | Elevated | 6 (14.6) | 0 | 5 (17.9) | 1 (12.5) | Â |
ALT (5–40 U/L) | Normal | 27 (65.9) | 5 (100) | 19 (67.9) | 3 (37.5) | 0.064 |
| Â | Elevated | 14 (34.1) | Â | 9 (32.1) | 5 (62.5) | Â |